Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 known ✓ | P00915 | 1/20 | 0.52 |
| ▸ | FABP3 | P05413 | 6/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.47 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.46 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.46 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.46 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1115447 | 1.00 | CA1 (0.52) | CA1FABP3EPHX1ALDH1A1TSHR | |
| SCHEMBL22534532 | 1.00 | CA1 (0.52) | CA1FABP3EPHX1ALDH1A1TSHR | |
| SCHEMBL6660469 | 1.00 | CA1 (0.52) | CA1FABP3EPHX1ALDH1A1TSHR | |
| SCHEMBL321998 | 0.98 | CA1 (0.54) | CA1FABP3EPHX1ALDH1A1TSHR | |
| SCHEMBL610050 | 0.96 | ALDH1A1 (0.50) | CA1FABP3EPHX1ALDH1A1TSHR | |
| Dodicin SCHEMBL29987916 | 0.96 | ALDH1A1 (0.50) | CA1FABP3EPHX1ALDH1A1TSHR | |
| SCHEMBL11627739 | 0.96 | FABP3 (0.50) | CA1FABP3EPHX1ALDH1A1TSHR | |
| SCHEMBL10484717 | 0.96 | FABP3 (0.50) | CA1FABP3EPHX1ALDH1A1TSHR | |
| Potassium Ion SCHEMBL6660182 | 0.96 | FABP3 (0.53) | CA1FABP3EPHX1ALDH1A1TSHR | |
| SCHEMBL29543143 | 0.96 | FABP3 (0.50) | CA1FABP3EPHX1ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115304712-A | Preparation method and application of amphoteric styrene-butadiene latex | 上海东升新材料有限公司 | 2022-11-08 | — | — | CN | claimed |
| EP-4525816-B1 | WAX DISPERSIONS | BASF SE (DE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4648740-A1 | USE OF UNSATURATED FATTY ACID AMIDOPROPYL BETAINES AS THICKENERS | BASF SE (DE) | 2025-11-19 | — | — | EP | disclosed |
| US-20250302729-A1 | Wax Dispersions | BASF SE (DE) | 2025-10-02 | — | — | US | disclosed |
| EP-4525816-A1 | WAX DISPERSIONS | BASF SE (DE) | 2025-03-26 | — | — | EP | disclosed |
| CN-119212671-A | Wax dispersion | 巴斯夫欧洲公司 | 2024-12-27 | — | — | CN | disclosed |
| WO-2024149652-A1 | BLENDS OF AMIDOPROPYL BETAINES DERIVED FROM FATTY ACID MIXTURES COMPRISING UNSATURATED FATTY ACIDS AND ALK(EN)YL (POLY)GLYCOSIDES | BASF SE (DE) | 2024-07-18 | — | — | WO | disclosed |
| WO-2024149654-A1 | USE OF UNSATURATED FATTY ACID AMIDOPROPYL BETAINES AS THICKENERS | BASF SE (DE) | 2024-07-18 | — | — | WO | disclosed |
| US-20240000686-A1 | PROCESS FOR PREPARING SURFACTANT SOLUTIONS WITH N-ACYL AMINO ACID SALTS | BASF SE (DE) | 2024-01-04 | — | — | US | disclosed |
| WO-2023222410-A1 | WAX DISPERSIONS | BASF SE (DE) | 2023-11-23 | — | — | WO | disclosed |
| US-20160152555-A1 | PROCESS FOR PREPARING N-ACYL AMINO ACID SALTS | STEPAN CO (US) | 2016-06-02 | — | — | US | disclosed |
| US-9156777-B2 | Process for preparing N-acyl amino acid salts | STEPAN COMPANY (US) | 2015-10-13 | — | — | US | disclosed |
| EP-2870136-A1 | PROCESS FOR PREPARING N-ACYL AMINO ACID SALTS | Stepan Company (US) | 2015-05-13 | — | — | EP | disclosed |
| US-20150126776-A1 | PROCESS FOR PREPARING N-ACYL AMINO ACID SALTS | STEPAN COMPANY | 2015-05-07 | — | — | US | disclosed |
| WO-2015026538-A1 | PROCESS FOR PREPARING N-ACYL AMINO ACID SALTS | STEPAN COMPANY (US) | 2015-02-26 | — | — | WO | disclosed |
| WO-2014008103-A1 | PROCESS FOR PREPARING N-ACYL AMINO ACID SALTS | STEPAN COMPANY (US) | 2014-01-09 | — | — | WO | disclosed |
| US-8623809-B2 | Pearlescent concentrate and process for production | OTC GMBH (DE) | 2014-01-07 | — | — | US | disclosed |
| EP-2470630-A2 | PEARLESCENT CONCENTRATE AND METHOD FOR PRODUCING THE SAME | OTC GmbH (DE) | 2012-07-04 | — | — | EP | disclosed |
| US-20120149629-A1 | PEARLESCENT CONCENTRATE AND PROCESS FOR PRODUCTION | OTC GMBH (DE) | 2012-06-14 | — | — | US | disclosed |
| WO-2011023803-A2 | PEARLESCENT CONCENTRATE AND METHOD FOR PRODUCING THE SAME | OTC GMBH (DE) | 2011-03-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250302729-A1 | Wax Dispersions | CUTA, DSG1, CYP17A1 | CA1 2882/4885FABP3 2227/4885EPHX1 1045/4885 |
| US-20240000686-A1 | PROCESS FOR PREPARING SURFACTANT SOLUTIONS WITH N-ACYL AMINO ACID SALTS | CUTA, SMURF1, SMURF2 | CA1 2883/4885FABP3 1084/4885EPHX1 2840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.